Lymphoblastic Lymphoma
Adult T type lymphoblastic lymphoma presenting as hypercalcemic crisis and aplastic anemia: a case report
... Case presentation: We report a case of a 52-year-old Cameroonian man with acute kidney injury who presented with confusion, abdominal pain, constipation, polyuria, polydipsia, calciphylaxis, enlarged lymph nodes, ...
7
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes
... grade lymphoma. The pathological diagnosis of T lymphoblastic lymphoma was made unequivocally by typical morphology and detailed immunophenotypical stu- ...grade lymphoma and therefore ...
5
A rare case of Primary Leptomeningeal Precursor B cell Lymphoblastic Lymphoma in a Pediatric Patient – Case report and Literature review
... intake significantly greater than caloric expenditure and subsequent intractable weight gain. The VMH promotes feeding through efferent neuropeptide Y and agouti-related peptide signalling and satiety via a-melanocyte ...
6
Nine Year Survival of Lymphoblastic Lymphoma Patients
... In conclusion, the Stanford/NCOG regimen may be an effective initial choice of therapy for lymphoblastic lymphoma patients. Peripheral blood stem cell transplantation should be man- dated after achieving ...
9
Acute B-Cell Lymphoblastic Leukemia/Acute B-Cell Lymphoblastic Lymphoma Presenting as Bilateral Breast Masses
... Case Report: A thirty-year-old woman has applied to our department with a four month story of painless masses in both of breasts. We have performed tru-cut biopsies to both breasts after clinical examination. ...
5
Gastrointestinal B-lymphoblastic lymphoma in a dog: a case report P. Borska 1*, R. Husnik2 , P. Fictum 1, A. Kehl3 , L. Leva 4, M. Faldyna4
... high-grade lymphoblastic lymphoma, flow cytometric analysis detected malignant cells of the immature B ...B-lymphoblastic lymphoma in a dog with survival equivalent to that of the multicentric ...
10
Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma
... Our study presents, for the first time, with a comprehensive study of FADD levels, phosphorylation status, regulators of FADD phosphorylation, FADD subcellular localization and function in T-cell lymphoblastic ...
15
Unusual presentation of primary T-cell lymphoblastic lymphoma: description of two cases
... On gross examination, a complete replacement of the testis by a fleshy, whitish, homogenous mass infiltrating the para-testicular tissues was observed. Microscopic- ally, an extensive infiltrate of blue uniform cells ...
6
Cutaneous Involvement in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
... In 15 cases, the skin lesions were observed within a median time of 6 weeks (range, a few days to 8 months) before the diagnosis of the hematologic dis- ease was made. Biopsies of the skin lesions were performed in 13 ...
7
Acute Renal Failure at Onset of Therapy for Advanced Stage Burkitt Lymphoma and B Cell Acute Lymphoblastic Lymphoma
... The pathogenesis of acute renal failure in chit- dren with tumor lysis syndrome is likely multifac- tonal and has generally been presumed to be due to the precipitation of phosphates, ur[r] ...
9
Pleiotropy Versus Heterogeneity in Proteus Syndrome
... Lymphoblastic lymphoma or Hodgkins lymphoma in hemophiliacs have also been reported at the World Fed- eration of Hemophilia International Congress.3’4 The au- thors suggest that lymphoma[r] ...
5
Clinical, hematological and cytogenetic profile in fibroblast growth factor receptor 1 rearranged hematoloymphoid malignancies
... FGFR1 rearrangements where three cases presented as T- cell lymphoblastic lymphoma (a rare form of aggressive non-Hodgkin’s lymphoma.) and one case as MPAL. The FGFR1 aberration was identified by ...
8
Evaluation of Prognostic Indicators in Non Hodgkin Lymphomas: The Role of Apoptotic and Proliferative Indices
... Ultrastructural examination is not routinely done in the identification of lymph node lesions, but it is inexpensive to fix the sample in glutaraldehyde which can be used later if needed. Electron microscopy is useful in ...
118
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
... Abstract: Nelarabine is the prodrug of 9-β-arabinofuranosylguanine (ara-G) and is therapeutically classified as a purine nucleoside analog. Nelarabine is converted to ara-G by adenosine deaminase and transported into ...
10
Case Report Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma
... B-cell lymphoma in comparison with that of CHOP ...acute lymphoblastic leukemia/lymphoblastic lymphoma (B-ALL/LBL) and hematogones, a normal precursor B-cell proliferation during regeneration ...
5
Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin
... a M, male; F, female; ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia; LL, lymphoblastic lymphoma; IFI, invasive fungal infection; SCT, stem cell transplantation; GVH[r] ...
5
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
... The recommended thromboprophylaxis included evalu- ation of antithrombin and fibrinogen levels prior to each asparaginase infusion and supplementation with fresh frozen plasma for fibrinogen levels below 0.5 g/L and with ...
10
Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer.
... Anaplastic lymphoma kinase; ALL, Adult lymphoblastic leukemia; CRISPR, Clustered regularly interspaced palindromic repeats; DAISY, Data-mining synthetic lethality identification pipeline; EGFR, Epidermal ...
49
Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia
... leukemia/ lymphoma, defined by a translocation involving MYC in combination with another translocation involving BCL2, warrant further study as they are not readily recognized until transformation has occurred and ...
7
Phase I trials using Sleeping Beauty to generate CD19 specific CAR T cells
... We thank the flow cytometry and cellular imaging core facili- ties at MD Anderson. We thank Pulvarthi Rao (Baylor College of Medicine) for karyotyping and George McNamara (MD Ander- son) for editing. The Cancer Center ...
15